Safe and effective treatments for everyone
Immunotherapy has revolutionized oncology and has the potential to change the way we diagnose and treat infectious and inflammatory diseases. We are developing innovative immunotherapies that are:
SAFE
Oral and nasal (no needles), fully synthetic; increases safety, deployability, geographic reach, compliance
Designed, studied and tested for adult and pediatric use
Targets are found on cancers and viruses but not normal human tissue (low risk of toxicity)
Fully human bispecific protein-Fc fusion that targets both PS and Man9, allowing for high therapeutic index
Low potential for immunogenicity
EFFECTIVE
Strain-agnostic
Infectious disease indications: Pandemic and Biodefense
Can be stock-piled for emergency preparedness
Oncology indications
Bypasses protein target drug resistance
Can be used as a decoy, with a payload (cytotoxic, immune modulator), or immune cell engager
SUSTAINABLE
Less invasive and mutation-agnostic technologies reduce drug development, distribution, medical and social costs
Eliminate health disparities by prioritizing solutions for neglected diseases and pediatric use